All Resources
App Note
Proteomic Barcoding Product Suite for CAR-T Therapy

Learn how Bruker Cellular Analysis’ Functional Proteomics reveals unique secretomic signatures and insights into CAR-T therapy.

Your data is secure. We keep your personal information safe and do not share it with any third parties. By submitting this form, you agree to receive communications from Bruker Cellular Analysis and accept our Privacy Policy. You may unsubscribe at any time.

What's Inside

In this App Note we discuss:

Overcoming challenges in CAR-T therapy and antigen escape in Multiple Myeloma
Preinfusion biomarkers for predicting clinical outcome in CAR-T cell treatment
Comparing subtle gene edits in NK cell therapies
Precision analytics in automated CAR-T manufacturing with single-cell proteomics
A Deeper Look

More about this App Note

Overcoming Challenges in CAR-T Therapy

Cell therapy relies on immune cells from patients or healthy donors, and in the case of allogeneic therapies, development and production are more complicated.

To ensure that these cell products are potent and effective, knowing how to engineer potency and durability throughout the development and bioprocessing stages is crucial.

Download this App Note to learn how Bruker Cellular Analysis can help you achieve this faster.

Get the App Note